Medical Care
Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Mar 27, 25
- ID: 162553
- Pages: 97
- Figures: 93
- Views: 42
The global CRISPR and CRISPR-Associated (Cas) Genes market size was US$ 2399 million in 2024 and is forecast to a readjusted size of US$ 16260 million by 2031 with a CAGR of 31.9% during the forecast period 2025-2031.
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell"s genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS"s choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
The global CRISPR and CRISPR-Associated (Cas) Genes market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
By Type: (Dominant Segment vs High-Margin Innovation)
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
By Application: (Core Demand Driver vs Emerging Opportunity)
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Thermo Fisher Scientific in Europe)
- Emerging Product Trends: Genome Editing adoption vs. Genetic engineering premiumization
- Demand-Side Dynamics: Biotechnology Companies growth in China vs. Pharmaceutical Companies potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of CRISPR and CRISPR-Associated (Cas) Genes market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Genetic engineering in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Pharmaceutical Companies in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the CRISPR and CRISPR-Associated (Cas) Genes value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell"s genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS"s choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
The global CRISPR and CRISPR-Associated (Cas) Genes market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
By Type: (Dominant Segment vs High-Margin Innovation)
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
By Application: (Core Demand Driver vs Emerging Opportunity)
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Thermo Fisher Scientific in Europe)
- Emerging Product Trends: Genome Editing adoption vs. Genetic engineering premiumization
- Demand-Side Dynamics: Biotechnology Companies growth in China vs. Pharmaceutical Companies potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of CRISPR and CRISPR-Associated (Cas) Genes market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Genetic engineering in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Pharmaceutical Companies in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the CRISPR and CRISPR-Associated (Cas) Genes value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Genome Editing
1.2.3 Genetic engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2020-2025)
2.4 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size and Prospective (2020-2031)
2.5.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size and Prospective (2020-2031)
2.5.3 China CRISPR and CRISPR-Associated (Cas) Genes Market Size and Prospective (2020-2031)
2.5.4 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Type (2020-2025)
3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2026-2031)
3.3 Different Types CRISPR and CRISPR-Associated (Cas) Genes Representative Players
4 Breakdown Data by Application
4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Application (2020-2025)
4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in CRISPR and CRISPR-Associated (Cas) Genes Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue (2020-2025)
5.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by CRISPR and CRISPR-Associated (Cas) Genes Revenue
5.4 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Analysis
5.4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2024
5.5 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes Head office and Area Served
5.6 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Product and Application
5.7 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025)
6.1.2.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025)
6.1.3.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025)
6.2.2.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025)
6.2.3.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025)
6.3.2.2 China CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025)
6.3.3.2 China CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025)
6.4.2.2 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025)
6.4.3.2 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Details
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.1.4 Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.1.5 Thermo Fisher Scientific Recent Development
7.2 Editas Medicine
7.2.1 Editas Medicine Company Details
7.2.2 Editas Medicine Business Overview
7.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.2.4 Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.2.5 Editas Medicine Recent Development
7.3 Caribou Biosciences
7.3.1 Caribou Biosciences Company Details
7.3.2 Caribou Biosciences Business Overview
7.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.3.4 Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.3.5 Caribou Biosciences Recent Development
7.4 CRISPR therapeutics
7.4.1 CRISPR therapeutics Company Details
7.4.2 CRISPR therapeutics Business Overview
7.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.4.4 CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.4.5 CRISPR therapeutics Recent Development
7.5 Intellia therapeutics, Inc.
7.5.1 Intellia therapeutics, Inc. Company Details
7.5.2 Intellia therapeutics, Inc. Business Overview
7.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.5.4 Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.5.5 Intellia therapeutics, Inc. Recent Development
7.6 Cellectis
7.6.1 Cellectis Company Details
7.6.2 Cellectis Business Overview
7.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.6.4 Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.6.5 Cellectis Recent Development
7.7 Horizon Discovery Plc
7.7.1 Horizon Discovery Plc Company Details
7.7.2 Horizon Discovery Plc Business Overview
7.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.7.4 Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.7.5 Horizon Discovery Plc Recent Development
7.8 Sigma Aldrich
7.8.1 Sigma Aldrich Company Details
7.8.2 Sigma Aldrich Business Overview
7.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.8.4 Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.8.5 Sigma Aldrich Recent Development
7.9 Precision Biosciences
7.9.1 Precision Biosciences Company Details
7.9.2 Precision Biosciences Business Overview
7.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.9.4 Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.9.5 Precision Biosciences Recent Development
7.10 Genscript
7.10.1 Genscript Company Details
7.10.2 Genscript Business Overview
7.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.10.4 Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.10.5 Genscript Recent Development
7.11 Sangamo Biosciences Inc.
7.11.1 Sangamo Biosciences Inc. Company Details
7.11.2 Sangamo Biosciences Inc. Business Overview
7.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.11.4 Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.11.5 Sangamo Biosciences Inc. Recent Development
7.12 Lonza Group Limited
7.12.1 Lonza Group Limited Company Details
7.12.2 Lonza Group Limited Business Overview
7.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.12.4 Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.12.5 Lonza Group Limited Recent Development
7.13 Integrated DNA Technologies
7.13.1 Integrated DNA Technologies Company Details
7.13.2 Integrated DNA Technologies Business Overview
7.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.13.4 Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.13.5 Integrated DNA Technologies Recent Development
7.14 New England Biolabs
7.14.1 New England Biolabs Company Details
7.14.2 New England Biolabs Business Overview
7.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.14.4 New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.14.5 New England Biolabs Recent Development
7.15 Origene Technologies
7.15.1 Origene Technologies Company Details
7.15.2 Origene Technologies Business Overview
7.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.15.4 Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.15.5 Origene Technologies Recent Development
8 CRISPR and CRISPR-Associated (Cas) Genes Market Dynamics
8.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends
8.2 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
8.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
8.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Genome Editing
1.2.3 Genetic engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2020-2025)
2.4 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size and Prospective (2020-2031)
2.5.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size and Prospective (2020-2031)
2.5.3 China CRISPR and CRISPR-Associated (Cas) Genes Market Size and Prospective (2020-2031)
2.5.4 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Type (2020-2025)
3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2026-2031)
3.3 Different Types CRISPR and CRISPR-Associated (Cas) Genes Representative Players
4 Breakdown Data by Application
4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Application (2020-2025)
4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in CRISPR and CRISPR-Associated (Cas) Genes Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue (2020-2025)
5.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by CRISPR and CRISPR-Associated (Cas) Genes Revenue
5.4 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Analysis
5.4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2024
5.5 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes Head office and Area Served
5.6 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Product and Application
5.7 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025)
6.1.2.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025)
6.1.3.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025)
6.2.2.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025)
6.2.3.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025)
6.3.2.2 China CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025)
6.3.3.2 China CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025)
6.4.2.2 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025)
6.4.3.2 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Details
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.1.4 Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.1.5 Thermo Fisher Scientific Recent Development
7.2 Editas Medicine
7.2.1 Editas Medicine Company Details
7.2.2 Editas Medicine Business Overview
7.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.2.4 Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.2.5 Editas Medicine Recent Development
7.3 Caribou Biosciences
7.3.1 Caribou Biosciences Company Details
7.3.2 Caribou Biosciences Business Overview
7.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.3.4 Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.3.5 Caribou Biosciences Recent Development
7.4 CRISPR therapeutics
7.4.1 CRISPR therapeutics Company Details
7.4.2 CRISPR therapeutics Business Overview
7.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.4.4 CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.4.5 CRISPR therapeutics Recent Development
7.5 Intellia therapeutics, Inc.
7.5.1 Intellia therapeutics, Inc. Company Details
7.5.2 Intellia therapeutics, Inc. Business Overview
7.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.5.4 Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.5.5 Intellia therapeutics, Inc. Recent Development
7.6 Cellectis
7.6.1 Cellectis Company Details
7.6.2 Cellectis Business Overview
7.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.6.4 Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.6.5 Cellectis Recent Development
7.7 Horizon Discovery Plc
7.7.1 Horizon Discovery Plc Company Details
7.7.2 Horizon Discovery Plc Business Overview
7.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.7.4 Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.7.5 Horizon Discovery Plc Recent Development
7.8 Sigma Aldrich
7.8.1 Sigma Aldrich Company Details
7.8.2 Sigma Aldrich Business Overview
7.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.8.4 Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.8.5 Sigma Aldrich Recent Development
7.9 Precision Biosciences
7.9.1 Precision Biosciences Company Details
7.9.2 Precision Biosciences Business Overview
7.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.9.4 Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.9.5 Precision Biosciences Recent Development
7.10 Genscript
7.10.1 Genscript Company Details
7.10.2 Genscript Business Overview
7.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.10.4 Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.10.5 Genscript Recent Development
7.11 Sangamo Biosciences Inc.
7.11.1 Sangamo Biosciences Inc. Company Details
7.11.2 Sangamo Biosciences Inc. Business Overview
7.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.11.4 Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.11.5 Sangamo Biosciences Inc. Recent Development
7.12 Lonza Group Limited
7.12.1 Lonza Group Limited Company Details
7.12.2 Lonza Group Limited Business Overview
7.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.12.4 Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.12.5 Lonza Group Limited Recent Development
7.13 Integrated DNA Technologies
7.13.1 Integrated DNA Technologies Company Details
7.13.2 Integrated DNA Technologies Business Overview
7.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.13.4 Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.13.5 Integrated DNA Technologies Recent Development
7.14 New England Biolabs
7.14.1 New England Biolabs Company Details
7.14.2 New England Biolabs Business Overview
7.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.14.4 New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.14.5 New England Biolabs Recent Development
7.15 Origene Technologies
7.15.1 Origene Technologies Company Details
7.15.2 Origene Technologies Business Overview
7.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
7.15.4 Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
7.15.5 Origene Technologies Recent Development
8 CRISPR and CRISPR-Associated (Cas) Genes Market Dynamics
8.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends
8.2 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
8.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
8.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Region (2020-2025)
Table 6. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share Forecast by Region (2026-2031)
Table 8. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2020-2025)
Table 10. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2020-2025)
Table 15. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in CRISPR and CRISPR-Associated (Cas) Genes Application
Table 18. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Players (2020-2025)
Table 20. Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2024)
Table 21. Ranking of Global Top CRISPR and CRISPR-Associated (Cas) Genes Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Headquarters and Area Served
Table 24. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Product and Application
Table 25. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2020-2025)
Table 29. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2020-2025)
Table 33. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & (US$ Million)
Table 35. China CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2020-2025) & (US$ Million)
Table 36. China CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2020-2025)
Table 37. China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025) & (US$ Million)
Table 38. China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2020-2025)
Table 41. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & (US$ Million)
Table 43. Thermo Fisher Scientific Company Details
Table 44. Thermo Fisher Scientific Business Overview
Table 45. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product
Table 46. Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 47. Thermo Fisher Scientific Recent Development
Table 48. Editas Medicine Company Details
Table 49. Editas Medicine Business Overview
Table 50. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product
Table 51. Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 52. Editas Medicine Recent Development
Table 53. Caribou Biosciences Company Details
Table 54. Caribou Biosciences Business Overview
Table 55. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
Table 56. Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 57. Caribou Biosciences Recent Development
Table 58. CRISPR therapeutics Company Details
Table 59. CRISPR therapeutics Business Overview
Table 60. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product
Table 61. CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 62. CRISPR therapeutics Recent Development
Table 63. Intellia therapeutics, Inc. Company Details
Table 64. Intellia therapeutics, Inc. Business Overview
Table 65. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
Table 66. Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 67. Intellia therapeutics, Inc. Recent Development
Table 68. Cellectis Company Details
Table 69. Cellectis Business Overview
Table 70. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product
Table 71. Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 72. Cellectis Recent Development
Table 73. Horizon Discovery Plc Company Details
Table 74. Horizon Discovery Plc Business Overview
Table 75. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product
Table 76. Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 77. Horizon Discovery Plc Recent Development
Table 78. Sigma Aldrich Company Details
Table 79. Sigma Aldrich Business Overview
Table 80. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product
Table 81. Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 82. Sigma Aldrich Recent Development
Table 83. Precision Biosciences Company Details
Table 84. Precision Biosciences Business Overview
Table 85. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
Table 86. Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 87. Precision Biosciences Recent Development
Table 88. Genscript Company Details
Table 89. Genscript Business Overview
Table 90. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product
Table 91. Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 92. Genscript Recent Development
Table 93. Sangamo Biosciences Inc. Company Details
Table 94. Sangamo Biosciences Inc. Business Overview
Table 95. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
Table 96. Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 97. Sangamo Biosciences Inc. Recent Development
Table 98. Lonza Group Limited Company Details
Table 99. Lonza Group Limited Business Overview
Table 100. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product
Table 101. Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 102. Lonza Group Limited Recent Development
Table 103. Integrated DNA Technologies Company Details
Table 104. Integrated DNA Technologies Business Overview
Table 105. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
Table 106. Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 107. Integrated DNA Technologies Recent Development
Table 108. New England Biolabs Company Details
Table 109. New England Biolabs Business Overview
Table 110. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product
Table 111. New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 112. New England Biolabs Recent Development
Table 113. Origene Technologies Company Details
Table 114. Origene Technologies Business Overview
Table 115. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
Table 116. Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 117. Origene Technologies Recent Development
Table 118. CRISPR and CRISPR-Associated (Cas) Genes Market Trends
Table 119. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
Table 120. CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
Table 121. CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Product Picture
Figure 2. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type: 2024 VS 2031
Figure 3. Genome Editing Features
Figure 4. Genetic engineering Features
Figure 5. gRNA Database/Gene Librar Features
Figure 6. CRISPR Plasmid Features
Figure 7. Human Stem Cells Features
Figure 8. Genetically Modified Organisms/Crops Features
Figure 9. Cell Line Engineering Features
Figure 10. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application: 2024 VS 2031
Figure 11. Biotechnology Companies
Figure 12. Pharmaceutical Companies
Figure 13. Academic Institutes
Figure 14. Research and Development Institutes
Figure 15. CRISPR and CRISPR-Associated (Cas) Genes Report Years Considered
Figure 16. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. China CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Players in 2024
Figure 24. Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2024)
Figure 25. The Top 10 and 5 Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2024
Figure 26. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2020-2025)
Figure 27. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2020-2025)
Figure 28. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2020-2025)
Figure 29. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2020-2025)
Figure 30. China CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2020-2025)
Figure 31. China CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2020-2025)
Figure 32. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2020-2025)
Figure 33. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2020-2025)
Figure 34. Thermo Fisher Scientific Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 35. Editas Medicine Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 36. Caribou Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 37. CRISPR therapeutics Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 38. Intellia therapeutics, Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 39. Cellectis Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 40. Horizon Discovery Plc Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 41. Sigma Aldrich Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 42. Precision Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 43. Genscript Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 44. Sangamo Biosciences Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 45. Lonza Group Limited Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 46. Integrated DNA Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 47. New England Biolabs Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 48. Origene Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Table 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Region (2020-2025)
Table 6. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share Forecast by Region (2026-2031)
Table 8. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2020-2025)
Table 10. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2020-2025)
Table 15. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in CRISPR and CRISPR-Associated (Cas) Genes Application
Table 18. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Players (2020-2025)
Table 20. Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2024)
Table 21. Ranking of Global Top CRISPR and CRISPR-Associated (Cas) Genes Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Headquarters and Area Served
Table 24. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Product and Application
Table 25. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2020-2025)
Table 29. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2020-2025)
Table 33. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & (US$ Million)
Table 35. China CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2020-2025) & (US$ Million)
Table 36. China CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2020-2025)
Table 37. China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025) & (US$ Million)
Table 38. China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2020-2025)
Table 41. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & (US$ Million)
Table 43. Thermo Fisher Scientific Company Details
Table 44. Thermo Fisher Scientific Business Overview
Table 45. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product
Table 46. Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 47. Thermo Fisher Scientific Recent Development
Table 48. Editas Medicine Company Details
Table 49. Editas Medicine Business Overview
Table 50. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product
Table 51. Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 52. Editas Medicine Recent Development
Table 53. Caribou Biosciences Company Details
Table 54. Caribou Biosciences Business Overview
Table 55. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
Table 56. Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 57. Caribou Biosciences Recent Development
Table 58. CRISPR therapeutics Company Details
Table 59. CRISPR therapeutics Business Overview
Table 60. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product
Table 61. CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 62. CRISPR therapeutics Recent Development
Table 63. Intellia therapeutics, Inc. Company Details
Table 64. Intellia therapeutics, Inc. Business Overview
Table 65. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
Table 66. Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 67. Intellia therapeutics, Inc. Recent Development
Table 68. Cellectis Company Details
Table 69. Cellectis Business Overview
Table 70. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product
Table 71. Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 72. Cellectis Recent Development
Table 73. Horizon Discovery Plc Company Details
Table 74. Horizon Discovery Plc Business Overview
Table 75. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product
Table 76. Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 77. Horizon Discovery Plc Recent Development
Table 78. Sigma Aldrich Company Details
Table 79. Sigma Aldrich Business Overview
Table 80. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product
Table 81. Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 82. Sigma Aldrich Recent Development
Table 83. Precision Biosciences Company Details
Table 84. Precision Biosciences Business Overview
Table 85. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
Table 86. Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 87. Precision Biosciences Recent Development
Table 88. Genscript Company Details
Table 89. Genscript Business Overview
Table 90. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product
Table 91. Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 92. Genscript Recent Development
Table 93. Sangamo Biosciences Inc. Company Details
Table 94. Sangamo Biosciences Inc. Business Overview
Table 95. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
Table 96. Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 97. Sangamo Biosciences Inc. Recent Development
Table 98. Lonza Group Limited Company Details
Table 99. Lonza Group Limited Business Overview
Table 100. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product
Table 101. Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 102. Lonza Group Limited Recent Development
Table 103. Integrated DNA Technologies Company Details
Table 104. Integrated DNA Technologies Business Overview
Table 105. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
Table 106. Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 107. Integrated DNA Technologies Recent Development
Table 108. New England Biolabs Company Details
Table 109. New England Biolabs Business Overview
Table 110. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product
Table 111. New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 112. New England Biolabs Recent Development
Table 113. Origene Technologies Company Details
Table 114. Origene Technologies Business Overview
Table 115. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
Table 116. Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 117. Origene Technologies Recent Development
Table 118. CRISPR and CRISPR-Associated (Cas) Genes Market Trends
Table 119. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
Table 120. CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
Table 121. CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Product Picture
Figure 2. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type: 2024 VS 2031
Figure 3. Genome Editing Features
Figure 4. Genetic engineering Features
Figure 5. gRNA Database/Gene Librar Features
Figure 6. CRISPR Plasmid Features
Figure 7. Human Stem Cells Features
Figure 8. Genetically Modified Organisms/Crops Features
Figure 9. Cell Line Engineering Features
Figure 10. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application: 2024 VS 2031
Figure 11. Biotechnology Companies
Figure 12. Pharmaceutical Companies
Figure 13. Academic Institutes
Figure 14. Research and Development Institutes
Figure 15. CRISPR and CRISPR-Associated (Cas) Genes Report Years Considered
Figure 16. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. China CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Players in 2024
Figure 24. Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2024)
Figure 25. The Top 10 and 5 Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2024
Figure 26. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2020-2025)
Figure 27. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2020-2025)
Figure 28. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2020-2025)
Figure 29. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2020-2025)
Figure 30. China CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2020-2025)
Figure 31. China CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2020-2025)
Figure 32. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2020-2025)
Figure 33. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2020-2025)
Figure 34. Thermo Fisher Scientific Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 35. Editas Medicine Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 36. Caribou Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 37. CRISPR therapeutics Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 38. Intellia therapeutics, Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 39. Cellectis Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 40. Horizon Discovery Plc Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 41. Sigma Aldrich Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 42. Precision Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 43. Genscript Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 44. Sangamo Biosciences Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 45. Lonza Group Limited Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 46. Integrated DNA Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 47. New England Biolabs Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 48. Origene Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232